María J. Maleno

Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection

Montserrat Plana, Felipe García, Teresa Gallart et al. · AIDS · 2000 · 92 citations

Life Sciences, Immunology, Infectious Diseases +17

Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02)

Felipe García, Juan Carlos López Bernaldo de Quirós, Carmen Gómez et al. · Vaccine · 2011 · 80 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Loading dendritic cells with gold nanoparticles (GNPs) bearing HIV-peptides and mannosides enhance HIV-specific T cell responses

Núria Climent, Isabel Garcı́a, Marco Marradi et al. · Nanomedicine Nanotechnology Biology and Medicine · 2017 · 57 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

In vitro effects of the CCR5 inhibitor maraviroc on human T cell function

Hodei Arberas, Alberto C. Guardo, Manel E. Bargalló et al. · Journal of Antimicrobial Chemotherapy · 2012 · 42 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Immunologic Reconstitution After 1 Year of Highly Active Antiretroviral Therapy, With or Without Protease Inhibitors

Montserrat Plana, Catalina Martínez, Felipe García et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2002 · 21 citations

Life Sciences, Immunology, Pharmacotherapy +17